Suppr超能文献

地诺单抗成功治疗两例因维生素D中毒及相关急性肾损伤导致高钙血症的病例。

Successful treatment with denosumab for two cases with hypercalcemia due to vitamin D intoxication and associated acute kidney injury.

作者信息

Barth Katharina, Sedivy Michal, Lindner Gregor, Schwarz Christoph

机构信息

Department of Internal Medicine 2, Pyhrn-Eisenwurzen Klinikum Steyr, Steyr, Austria.

Department of Internal Medicine 1, Pyhrn-Eisenwurzen Klinikum Steyr, Sierningerstraße 170, 4400, Steyr, Austria.

出版信息

CEN Case Rep. 2022 Feb;11(1):141-145. doi: 10.1007/s13730-021-00643-5. Epub 2021 Sep 13.

Abstract

Hypervitaminosis D is a rare reason for hypercalcemia and associated with acute kidney injury. We report on two cases of hypercalcemia and acute kidney injury because of vitamin D intoxication successfully treated with denosumab. Case 1 is an 83-year-old woman, who was initially treated for 2 weeks with intravenous hydration, steroids and thereafter with furosemide without any effect on serum calcium levels and renal function. Because acute renal failure discouraged us to use intravenous bisphosphonate therapy, we applicated 60 mg denusomab subcutaneously. This led to a prompt reduction in serum calcium levels and improvement of renal function within 1 week. Case 2 is a 45-year-old athletic woman, who refused the standard therapy of steroids and forced diuresis for vitamin D intoxication. After 1 day of rehydration therapy, she received 60 mg denusomab. Similar to case 1 serum calcium declined and renal function improved within 7 days.

摘要

维生素D过多症是高钙血症的罕见病因,且与急性肾损伤相关。我们报告两例因维生素D中毒导致高钙血症和急性肾损伤的病例,经地诺单抗成功治疗。病例1是一名83岁女性,最初接受了2周的静脉补液、类固醇治疗,之后使用呋塞米治疗,但血清钙水平和肾功能均无改善。由于急性肾衰竭使我们不敢使用静脉双膦酸盐治疗,我们皮下注射了60mg地诺单抗。这导致血清钙水平迅速降低,肾功能在1周内得到改善。病例2是一名45岁的运动女性,她拒绝了维生素D中毒的类固醇和强制利尿标准治疗。补液治疗1天后,她接受了60mg地诺单抗。与病例1相似,血清钙在7天内下降,肾功能改善。

相似文献

2
Denosumab for the treatment of bisphosphonate resistant hypercalcemia in a hemodialysis patient.
Saudi J Kidney Dis Transpl. 2017 Jan-Feb;28(1):154-157. doi: 10.4103/1319-2442.198239.
3
Too Much of a Good Thing: Severe Hypercalcemia Presenting with Lethargy and Kidney Failure.
Praxis (Bern 1994). 2024 Apr;113(4):106-110. doi: 10.23785/PRAXIS.2024.04.005.
4
[A case report of severe vitamin D intoxication].
MMW Fortschr Med. 2020 Nov;162(Suppl 7):15-18. doi: 10.1007/s15006-020-4502-9.
5
Denosumab for the Treatment of Hypercalcemia in a Patient With Parathyroid Carcinoma: A Case Report.
Front Endocrinol (Lausanne). 2022 Jan 31;12:794988. doi: 10.3389/fendo.2021.794988. eCollection 2021.
6
Denosumab treatment for refractory hypercalcemia in a hemodialysis patient with tertiary hyperparathyroidism.
Hemodial Int. 2023 Apr;27(2):E23-E28. doi: 10.1111/hdi.13063. Epub 2023 Jan 31.
8
Denosumab for treatment of immobilization-related hypercalcemia in a patient with end-stage renal disease.
CEN Case Rep. 2017 May;6(1):111-114. doi: 10.1007/s13730-017-0254-5. Epub 2017 Feb 27.
9
Acute renal failure and hypercalcemia in an athletic young man.
Clin Nephrol. 2009 Apr;71(4):445-7. doi: 10.5414/cnp71445.
10
Hypercalcemia: A Review.
JAMA. 2022 Oct 25;328(16):1624-1636. doi: 10.1001/jama.2022.18331.

引用本文的文献

1
Vitamin D and Acute Kidney Injury: A Reciprocal Relationship.
Biomolecules. 2025 Apr 15;15(4):586. doi: 10.3390/biom15040586.
2
Teriparatide-Associated Hypercalcemia Concomitant With Acute Kidney Injury: A Case-Report.
Cureus. 2024 Feb 15;16(2):e54263. doi: 10.7759/cureus.54263. eCollection 2024 Feb.
3
Vitamin D status among residents of Molidawa Daur Autonomous Banner, Inner Mongolia, North China.
Saudi Med J. 2023 Apr;44(4):413-420. doi: 10.15537/smj.2023.44.4.20220780.

本文引用的文献

1
Safety of Intravenous Bisphosphonates for the Treatment of Hypercalcemia in Patients With Preexisting Renal Dysfunction.
Ann Pharmacother. 2021 Mar;55(3):303-310. doi: 10.1177/1060028020953501. Epub 2020 Aug 27.
2
Abstracts - 22nd International Conference on Dialysis Advances inChronic Kidney Disease 2020.
Blood Purif. 2020;49(1-2):232-253. doi: 10.1159/000505257. Epub 2019 Dec 19.
3
Epidemiology, clinical features, and management of severe hypercalcemia in critically ill patients.
Ann Intensive Care. 2019 Nov 27;9(1):133. doi: 10.1186/s13613-019-0606-8.
5
Vitamin D Toxicity-A Clinical Perspective.
Front Endocrinol (Lausanne). 2018 Sep 20;9:550. doi: 10.3389/fendo.2018.00550. eCollection 2018.
7
Histochemical examination of the effects of high-dose 1,25(OH)2D3 on bone remodeling in young growing rats.
J Mol Histol. 2016 Aug;47(4):389-99. doi: 10.1007/s10735-016-9681-4. Epub 2016 Jun 2.
8
Denosumab: a new agent in the management of hypercalcemia of malignancy.
Future Oncol. 2015;11(21):2865-71. doi: 10.2217/fon.15.232. Epub 2015 Sep 25.
9
Denosumab for treatment of immobilization-related hypercalcaemia in a patient with advanced renal failure.
Clin Kidney J. 2012 Dec;5(6):566-71. doi: 10.1093/ckj/sfs116. Epub 2012 Oct 7.
10
Changing Incidence of Serum 25-Hydroxyvitamin D Values Above 50 ng/mL: A 10-Year Population-Based Study.
Mayo Clin Proc. 2015 May;90(5):577-86. doi: 10.1016/j.mayocp.2015.02.012.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验